Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1972 2
1973 2
1975 3
1976 1
1977 4
1978 9
1979 8
1980 5
1981 5
1982 7
1983 2
1984 3
1985 7
1986 7
1987 9
1988 9
1989 14
1990 13
1991 18
1992 18
1993 14
1994 9
1995 12
1996 18
1997 26
1998 25
1999 22
2000 20
2001 29
2002 27
2003 31
2004 30
2005 52
2006 52
2007 41
2008 62
2009 62
2010 83
2011 73
2012 81
2013 74
2014 105
2015 110
2016 105
2017 140
2018 154
2019 139
2020 156
2021 179
2022 174
2023 165
2024 89

Text availability

Article attribute

Article type

Publication date

Search Results

2,233 results

Results by year

Filters applied: . Clear all
Page 1
Artificial Tears: A Systematic Review.
Semp DA, Beeson D, Sheppard AL, Dutta D, Wolffsohn JS. Semp DA, et al. Clin Optom (Auckl). 2023 Jan 10;15:9-27. doi: 10.2147/OPTO.S350185. eCollection 2023. Clin Optom (Auckl). 2023. PMID: 36647552 Free PMC article. Review.
Not all patients with dry eye disease benefit from artificial tears, so if there is no benefit over a month, alternative management should be considered. ...Those classified as having evaporative dry eye disease, benefit from artificial tears …
Not all patients with dry eye disease benefit from artificial tears, so if there is no benefit over a month, alternativ …
Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease.
Labetoulle M, Benitez-Del-Castillo JM, Barabino S, Herrero Vanrell R, Daull P, Garrigue JS, Rolando M. Labetoulle M, et al. Int J Mol Sci. 2022 Feb 23;23(5):2434. doi: 10.3390/ijms23052434. Int J Mol Sci. 2022. PMID: 35269576 Free PMC article. Review.
Dry eye disease (DED) is the most common ocular surface disease, characterized by insufficient production and/or instability of the tear film. ...
Dry eye disease (DED) is the most common ocular surface disease, characterized by insufficient production and/or instability of the t …
Role of rheology in tears and artificial tears.
A Arshinoff S, Hofmann I, Nae H. A Arshinoff S, et al. J Cataract Refract Surg. 2021 May 1;47(5):655-661. doi: 10.1097/j.jcrs.0000000000000508. J Cataract Refract Surg. 2021. PMID: 33278231 Review.
The study of viscoelastic fluids as artificial tears dates back to the late 1970s. Healon, the first ophthalmic viscosurgical device, was approved in 1980, but studied extensively before then, exhibits very interesting shear-thinning properties that were found to be …
The study of viscoelastic fluids as artificial tears dates back to the late 1970s. Healon, the first ophthalmic viscosurgical …
Artificial tears potpourri: a literature review.
Moshirfar M, Pierson K, Hanamaikai K, Santiago-Caban L, Muthappan V, Passi SF. Moshirfar M, et al. Clin Ophthalmol. 2014 Jul 31;8:1419-33. doi: 10.2147/OPTH.S65263. eCollection 2014. Clin Ophthalmol. 2014. PMID: 25114502 Free PMC article. Review.
Numerous brands and types of artificial tears are available on the market for the treatment of dysfunctional tear syndrome. ...Fifty-one studies evaluating different brands of artificial tears, and their efficacy were identified. Out of the 51 studies, …
Numerous brands and types of artificial tears are available on the market for the treatment of dysfunctional tear syndrome. .. …
Artificial tears: Promising treatment or silent threat to public health?
Mughal S, Sakina SK. Mughal S, et al. Health Sci Rep. 2023 Aug 24;6(8):e1508. doi: 10.1002/hsr2.1508. eCollection 2023 Aug. Health Sci Rep. 2023. PMID: 37636283 Free PMC article.
EzriCare Artificial Tears are preservative-free, multi-dose, readily accessible eye drops containing carboxymethylcellulose sodium solution (10 mg in 1 ml) aiming for relief against DED. ...METHODS: We searched for articles documenting the incidence of …
EzriCare Artificial Tears are preservative-free, multi-dose, readily accessible eye drops containing carboxymeth …
Rheological Behavior Patterns in Artificial Tears.
Blasco-Martinez A, Mateo-Orobia A, Blasco-Alberto J, Pablo-Julvez L. Blasco-Martinez A, et al. Optom Vis Sci. 2022 May 1;99(5):455-462. doi: 10.1097/OPX.0000000000001885. Epub 2022 Feb 25. Optom Vis Sci. 2022. PMID: 35511122
PURPOSE: This study aimed to describe, in an objective way, the rheological behavior of several artificial tears. METHODS: Seventy-eight artificial tears were included in this experimental analytical study. ...RESULTS: Four rheological patterns with di …
PURPOSE: This study aimed to describe, in an objective way, the rheological behavior of several artificial tears. METHODS: Sev …
The pathophysiology, diagnosis, and treatment of dry eye disease.
Messmer EM. Messmer EM. Dtsch Arztebl Int. 2015 Jan 30;112(5):71-81; quiz 82. doi: 10.3238/arztebl.2015.0071. Dtsch Arztebl Int. 2015. PMID: 25686388 Free PMC article. Review.
Few randomized controlled therapeutic trials for dry eye have been published to date. Artificial tears of various kinds are recommended if the symptoms are mild. ...The benefit of long-term topical anti-inflammatory treatment of moderate or severe dry eye …
Few randomized controlled therapeutic trials for dry eye have been published to date. Artificial tears of various kinds …
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies.
Ramos-Casals M, Brito-Zerón P, Bombardieri S, Bootsma H, De Vita S, Dörner T, Fisher BA, Gottenberg JE, Hernandez-Molina G, Kocher A, Kostov B, Kruize AA, Mandl T, Ng WF, Retamozo S, Seror R, Shoenfeld Y, Sisó-Almirall A, Tzioufas AG, Vitali C, Bowman S, Mariette X; EULAR-Sjögren Syndrome Task Force Group. Ramos-Casals M, et al. Ann Rheum Dis. 2020 Jan;79(1):3-18. doi: 10.1136/annrheumdis-2019-216114. Epub 2019 Oct 31. Ann Rheum Dis. 2020. PMID: 31672775
The recommendations address the use of topical oral (saliva substitutes) and ocular (artificial tear drops, topical non-steroidal anti-inflammatory drugs, topical corticosteroids, topical CyA, serum tear drops) therapies, oral muscarinic agonists (pilocarpine …
The recommendations address the use of topical oral (saliva substitutes) and ocular (artificial tear drops, topical non-steroi …
A Review of the Compatibility of Topical Artificial Tears and Rewetting Drops with Contact Lenses.
Pucker AD. Pucker AD. Cont Lens Anterior Eye. 2020 Oct;43(5):426-432. doi: 10.1016/j.clae.2020.04.013. Epub 2020 May 12. Cont Lens Anterior Eye. 2020. PMID: 32409235 Review.
METHODS: Manuscripts were obtained by searching PubMed with the term "contact lens" and "artificial tears" or "rewetting drops" or "lubricant". Recovered texts were searched to find additional references. ...CONCLUSION: Over-the-counter, topical, ar …
METHODS: Manuscripts were obtained by searching PubMed with the term "contact lens" and "artificial tears" or "rewetting dr …
2,233 results